Merck makes a big move into new cancer treatments with a $6.7 billion
buyout deal
-
Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is
developing an oral treatment for leukemia.
32 minutes ago
Posts
Seed Newsvine
.jpg)
No comments:
Post a Comment